Stocks to Watch:

RETRANSMISSION: BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

Marketwired
RETRANSMISSION: BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion
Thallion Pharmaceuticals Inc. and BELLUS Health Inc. Logo
View Comments (0)